0690.HK Tiesioginiai signalai | Didinkite pelną su Getagraph.com

Live Chart Being Loaded With Signals

Commentary (3 geg. 2024 @ 05:29):

Stats
Šios dienos apimtis	1.06M
Vidutinė apimtis	4.96M
Rinkos kapitalizacija	522.67M
EPS	HKD0 ( 2023-08-28 )
Kita pelno data	( HKD0 ) 2024-05-16
Last Dividend	HKD0.00224 ( 2007-08-22 )
Next Dividend	HKD0 ( N/A )
P/E	8.60
ATR14	HKD0.00100 (1.16%)

Uni-Bio Science Group Koreliacija

10 Labiausiai teigiamai susiję koreliacijos

10 Labiausiai neigiamai susiję koreliacijos

Ar žinojote?

Koreliacija yra statistinis rodiklis, aprašantis ryšį tarp dviejų kintamųjų. Jis svyruoja nuo -1 iki 1, kur -1 reiškia tobulo neigiamo ryšio koreliaciją (padidėjus vienam kintamajam, sumažėja kitas), 1 reiškia tobulo teigiamo ryšio koreliaciją (padidėjus vienam kintamajam, padidėja ir kitas), o 0 reiškia jokios koreliacijos (tarp kintamųjų nėra jokio ryšio).

Koreliacija gali būti naudojama analizuojant bet kurių dviejų kintamųjų ryšį, ne tik akcijų. Jis dažnai naudojamas finansų, ekonomikos, psichologijos ir kitose srityse.

Uni-Bio Science Group Finansinės ataskaitos

Annual	2023
Pajamos:	HKD484.72M
Bruto pelnas:	HKD390.46M (80.55 %)
EPS:	HKD0.0111

FY	2023
Pajamos:	HKD484.72M
Bruto pelnas:	HKD390.46M (80.55 %)
EPS:	HKD0.0111

FY	2022
Pajamos:	HKD440.32M
Bruto pelnas:	HKD334.88M (76.06 %)
EPS:	HKD0.00600

FY	2021
Pajamos:	HKD353.41M
Bruto pelnas:	HKD277.01M (78.38 %)
EPS:	HKD-0.00306

Financial Reports:

No articles found.

Uni-Bio Science Group Dividends

(Q3/22)	(Q4/22)	(Q1/23)	(Q2/23)	(Q3/23)	(Q4/23)	(Q1/24)	(Q2/24)	(Q3/24)	(Q4/24)
HKD0 (N/A)	HKD0 (N/A)	HKD0 (N/A)	HKD0 (N/A)	HKD0 (N/A)	HKD0 (N/A)	HKD0 (N/A)	HKD0 (N/A)	HKD0 (N/A)	HKD0 (N/A)

Uni-Bio Science Group Dividend Information - Ex Dividend Junior

Dividend Sustainability Score: 10.00 - good (100.00%) | Divividend Growth Potential Score: 4.31 - Potential for dividend initiation, but uncertain (13.75%)

Information

First Dividend	HKD0.00224	2007-08-22
Last Dividend	HKD0.00224	2007-08-22
Next Dividend	HKD0	N/A
Payout Date	0000-00-00
Next Payout Date	N/A
# dividends	1	--
Total Paid Out	HKD0.00224	--
Avg. Dividend % Per Year	0.00%	--
Score	2.37	--
Div. Sustainability Score	10.00
Div.Growth Potential Score	4.31
Div. Directional Score	7.86	--

Next Divdend (Est)
(2024-05-03)

HKD0 Estimate 0.00 %

Dividend Stability

0.00 Very Bad

Dividend Score

2.37

Pay Frequency

Insufficient data to determine frequency

Yearly Payout

Year	Amount	Yield

Dividend Commentary

The company's strong Dividend Sustainability Score (DSS) indicates its robust capacity to uphold current dividend levels. Unfortunately, its low Dividend Growth Potential Score (DGPS) suggests limited prospects for dividend growth. In summary, the company provides a promising overall dividend outlook, balancing both sustainability and growth potential.

Top 10 dividend Companies for HKSE

Symbol	Title	Last dividend	Frequency	Yearly Dividend
2368.HK	Ex Dividend Knight	2023-08-25	Semi-Annually	0.00%
1357.HK	Ex Dividend Junior	2023-06-05	Insufficient data to determine frequency	0.00%
0398.HK	Ex Dividend Knight	2023-09-29	Semi-Annually	0.00%
6690.HK	Ex Dividend Knight	2023-07-24	Annually	0.00%
1905.HK	Ex Dividend Knight	2023-10-20	Semi-Annually	0.00%
0934.HK	Ex Dividend Knight	2023-09-14	Semi-Annually	0.00%
0057.HK	Ex Dividend Knight	2023-09-01	Semi-Annually	0.00%
2885.HK	Ex Dividend Junior	2023-06-15	Annually	0.00%
1501.HK	Ex Dividend Junior	2023-05-24	Annually	0.00%
0552.HK	Ex Dividend Junior	2023-07-03	Annually	0.00%

Dividend Sustainability Score (DSS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
netProfitMarginTTM	0.146	1.500	7.08	10.00	[0 - 0.5]
returnOnAssetsTTM	0.259	1.200	1.356	1.628	[0 - 0.3]
returnOnEquityTTM	0.441	1.500	6.21	9.31	[0.1 - 1]
payoutRatioTTM	0	-1.000	0	0	[0 - 1]
currentRatioTTM	2.07	0.800	4.63	3.70	[1 - 3]
quickRatioTTM	1.870	0.800	3.71	2.96	[0.8 - 2.5]
cashRatioTTM	1.126	1.500	4.86	7.28	[0.2 - 2]
debtRatioTTM	0.112	-1.500	8.14	-10.00	[0 - 0.6]
interestCoverageTTM	139.39	1.000	10.00	10.00	[3 - 30]
operatingCashFlowPerShareTTM	0.0180	2.00	9.99	10.00	[0 - 30]
freeCashFlowPerShareTTM	0.0180	2.00	9.99	10.00	[0 - 20]
debtEquityRatioTTM	0.178	-1.500	9.29	-10.00	[0 - 2.5]
grossProfitMarginTTM	0.807	1.000	10.00	10.00	[0.2 - 0.8]
operatingProfitMarginTTM	0.150	1.000	9.00	9.00	[0.1 - 0.6]
cashFlowToDebtRatioTTM	2.50	1.000	10.00	10.00	[0.2 - 2]
assetTurnoverTTM	1.773	0.800	1.511	1.209	[0.5 - 2]
Total Score				11.41

Dividend Growth Score (DGS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
peRatioTTM	5.15	1.000	9.58	0	[1 - 100]
returnOnEquityTTM	0.441	2.50	7.56	9.31	[0.1 - 1.5]
freeCashFlowPerShareTTM	0.0180	2.00	9.99	10.00	[0 - 30]
dividendYielPercentageTTM	0	1.500	0	0	[0 - 0.4]
operatingCashFlowPerShareTTM	0.0180	2.00	9.99	10.00	[0 - 30]
payoutRatioTTM	0	1.500	0	0	[0 - 1]
pegRatioTTM	-0.00179	1.500	-3.35	0	[0.5 - 2]
operatingCashFlowSalesRatioTTM	0.158	1.000	8.56	0	[0.1 - 0.5]
Total Score				4.31

Uni-Bio Science Group

Uni-Bio Science Group Limited, an investment holding company, engages in the research and development, manufacture, and sale of biological and chemical pharmaceutical products to treat human diseases in the People's Republic of China. The company provides GeneTime, a prescription biological drug for wound healing; GeneSoft, an EGF eye drop for dry eye syndrome, corneal damage, and post-operative healing; Pinup, a voriconazole tablet to treat severe fungal infections; and Bokangtai, a mitiglinide tablet for the treatment of Type 2 diabetes, as well as Boshutai, an oral anti-diabetic drug targeting patients with pre-diabetes condition. It is also developing prescription drugs, including rExendin-4 (Uni-E4) for Type 2 diabetes; and rhPTH 1-34 (Uni-PTH) for the treatment of osteoporosis in postmenopausal women, as well as Uni-GLP, a GLP-1 agonist, a non-insulin treatment candidate for the treatment of Type 2 diabetes. The company was founded in 2001 and is headquartered in Sha Tin, Hong Kong.